Bristol Myers Squibb Builds Enterprise Data Lakes on AWS

Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Before moving to the Amazon Web Services (AWS) Cloud, Bristol Myers Squibb was building data lakes using various tools and methods, which created inconsistencies, technical debt, and a higher cost to run. Brian Zellner, associate director of R&D data lakes at Bristol Myers Squibb, says, “When we moved to AWS, we started with a multi-tenant concept that allows us to use services in a consistent way.”

In addition, Bristol Myers Squibb is leveraging AWS Glue to build out a scalable infrastructure with a pay-as-you-go model, which "gave us great advantage over what we were doing before, so we’re able to ingest data faster and transform it and get faster insights,” says Zellner.

“Speed is a core tenant of what we’re trying to do at Bristol Myers Squibb. The faster that we can develop drugs, the sooner they can get to the patients who need them,” explains Zellner.